+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Endocrinology Drug"

From
From
Global Endocrinology Drugs Market 2023-2027 - Product Thumbnail Image

Global Endocrinology Drugs Market 2023-2027

  • Report
  • November 2022
  • 120 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

The Endocrinology Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market, which focuses on drugs used to treat endocrine and metabolic disorders. These drugs are used to treat a variety of conditions, including diabetes, thyroid disorders, obesity, and growth hormone deficiency. Endocrinology drugs are typically administered orally, intravenously, or subcutaneously. They can also be administered through inhalation or injection. Endocrinology drugs are typically developed by pharmaceutical companies and are subject to stringent regulatory approval processes. These drugs are often expensive and require ongoing monitoring and management. Some of the major companies in the Endocrinology Drug market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Pfizer. Show Less Read more